Search

eISSN: 2345-4202

Submit Your Paper Editorial Board Publication Fee Archive

Indexing Information

Journal of Nephropharmacology follows the guidelines of COPE

Follower of the International Committee of Medical Journal Editors

We are follower of World Association of Medical Editors

2025, Vol 14, No. 1

Publisher

Society of Diabetic Nephropathy Prevention

Review

1. Immune-related adverse kidney events by immune checkpoint inhibitors; a narrative review on current studies

Tella Sadighpour* , Celeste Cagnazzo , Shahrzad Alimohammadi , Anahita Emami , Azadeh Khayyat, Mohammad Ali EsmaeilPour

J Nephropharmacol. 2021;10(2): e22. doi: 10.34172/npj.2021.22

Scopus ID: 85111448122

Article

PDF

XML

Cited By:

0

1

Mini Review

2. Nephrotoxicity of checkpoint inhibitors; a current challenge

Samaneh Zandifar , Mahshid Imankhan , Padideh Daneii , Ali Azarpey* , Leila Alem*

J Nephropharmacol. 2024;13(1): e10641. doi: 10.34172/npj.2023.10641

Article

PDF

XML

Cited By:

0

Mini-Review

3. Acute kidney injury following cancer immunotherapy; collaboration of oncologists and nephrologists

Sousan Mohammadi Kebar , Saeed Hoseininia*

J Nephropharmacol. 2025;14(1): e12696. doi: 10.34172/npj.2024.12696

Article

PDF

XML

Cited By:

Mini-Review

4. Immune checkpoint inhibitors and IgA nephropathy; A rare side effect

Maryam Dehghani Mobarakeh , Ahmadreza Maghsoudi*

J Nephropharmacol. 2025;. doi: 10.34172/npj.2025.12762

Article

PDF

XML

Cited By: